Bacterial otitis media: a vaccine preventable disease?

Related Experiment Video

Updated: Aug 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Allan W Cripps1, Diana C Otczyk, Jennelle M Kyd

  • 1School of Medicine, Griffith University, Gold Coast Campus, PMB 50, Gold Coast MC, Qld 9726, Australia. allan.cripps@griffith.edu.au

Vaccine
|March 10, 2005
PubMed

Insights

Otitis media (OM), a common childhood illness, necessitates new treatments due to antibiotic resistance. Developing a combined bacterial-viral vaccine is crucial for reducing global OM incidence.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Otitis media (OM) is a prevalent childhood illness causing significant morbidity and economic burden.
  • Bacterial and viral infections are primary causes, with nontypeable Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis being key pathogens.
  • Increasing antibiotic resistance necessitates alternative therapeutic strategies like vaccination.

Purpose of the Study:

  • To highlight the limitations of current treatments for otitis media.
  • To propose the development of a novel vaccine for bacterial otitis media.
  • To advocate for a combined bacterial-viral vaccine formulation to combat OM.

Main Methods:

  • Review of current literature on otitis media causes and treatments.
  • Analysis of the effectiveness of existing vaccines, including pneumococcal polysaccharide vaccination.
  • Identification of key bacterial and viral antigens for vaccine development.

Main Results:

  • Current antibiotic treatments face challenges due to rising microbial resistance.
  • Pneumococcal polysaccharide vaccination has shown limited effectiveness in preventing OM and has led to an increase in non-vaccine serotypes.
  • An effective bacterial OM vaccine would require combining antigens from H. influenzae, S. pneumoniae, and M. catarrhalis.

Conclusions:

  • A multifaceted vaccine approach is needed to address the complex etiology of otitis media.
  • A combined bacterial-viral vaccine holds the most promise for significantly reducing the global incidence of OM.
  • Further research into combined vaccine formulations is essential for effective otitis media prevention.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...